US$ 20.54
glp-1/gip agonist The Emerging Role of Dual GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction GI Adverse Effects of Glucagon-Like
Description
M.(2022)

Ten Kulve, J

doi: 10.2337/db14-0302

These medications work by mimicking the glucagon-like peptide-1 (GLP-1) hormone, which helps control blood sugar levels and promotes weight loss
Short-term combined treatment with exenatide and metformin for overweight/obese women with polycystic ovary syndrome

Publication bias was assessed with the Egger test [20]
